Confidentiality restrictions around clinical trials and prior public use (T 0670/20)
The IPKat
JANUARY 31, 2023
The question became whether the patients could be considered members of the public, and whether their participation in the clinical trial therefore constituted prior public use of the formulation. The disclosure requirements stipulated by regulatory authorities are also increasing, most notably in Europe.
Let's personalize your content